Feds Pressed To Ease Access To Monkeypox Med

Gothamist reports:

Advocates and lawmakers are calling for the Biden administration to remove barriers to access for a promising medication called tecovirimat, or TPOXX, as New York’s monkeypox outbreak worsens.

So far, the U.S. Food and Drug Administration has only approved the medication for the treatment of smallpox — though some early studies show TPOXX can help against monkeypox, too.

If a health care provider wants to try TPOXX for a monkeypox patient, they have to obtain special approval through the CDC and its “Investigational New Drug” program.

Read the full article.

“a dozen state legislators sent a letter to Xavier Becerra [HHS secretary], urging him to consider an emergency use authorization for TPOXX, similar to the ones issued for COVID-19 vaccines before they were fully approved” https://t.co/j3NfhHKbF3

— Druckenmiller’s Intern (@DrucksIntern) August 3, 2022